Objectives: Administering proton pump inhibitors (PPI)
intravenously (iv) after endoscopic treatment of bleeding
peptic ulcers reduces the incidence of rebleeding, the
need for operative procedures, and hospitalizations. We
assessed the cost implications of iv PPI initiated in all
patients presenting to the emergency department (ED)
with signs of upper gastrointestinal (UGI) bleeding.